Shares of Pacific Biosciences of California Inc. ( (PACB - Get Report) ) were lower after the U.K. antitrust authority expressed concern that the company's plan to be acquired by Illumina Inc. ( (ILMN - Get Report) ) could hurt competition...
...Pacific Biosciences "recently released a new, innovative system for DNA sequencing ... which means that it is well-positioned to offer stronger competition to Illumina," the agency said in a statement.